RENO, Nevada, Feb. 23, 2020 /PRNewswire/ -- Screening at airports using heat sensors for elevated temperatures may identify those who have later-stage symptoms of fever from coronavirus or other unrelated illnesses such as the common cold or flu.  Airport tissue-sample screening should be implemented immediately for all inbound international passengers t

MEMPHIS, Tenn., Feb. 23, 2020 /PRNewswire/ -- During the 5th annual St. Jude Spirit of the Dream, St. Jude Children's Research Hospital®

PETAH TIKVA, Israel, Feb. 23, 2020 /PRNewswire/ -- PolyPid Ltd. today announced that it intends to confidentially submit a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") relating to a potential initial public offering of its ordinary shares in the United States

NEW YORK, Feb. 23, 2020 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that on February 21, 2020, a special committee of the Board of Directors of Spherix Incorporated ("Spherix") approved a distribution to Spherix stockholders of 70,000 shares of Hoth Therapeutics, Inc. ("Hoth") held by Spherix.

WASHINGTON, Feb. 22, 2020 /PRNewswire/ -- Today, the Association of Black Cardiologists (ABC), Inc., is excited to kick off the official Heart Valve Disease (HVD) Awareness Day activities with a public community educational health event hosted by the Alliance for Aging Research and The Greater Harlem Chamber of Commerce.

BEIJING, Feb. 21, 2020 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ:ZCMD), a provider of healthcare information, professional training and educational services to healthcare professionals and the public in China, today announced the pricing of its initial public offering of 3,000,00

INDIANAPOLIS, Feb. 21, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who have established cardiovascular (CV) disease or multiple cardiovascular risk fa

MEMPHIS, Tenn., Feb. 21, 2020 /PRNewswire/ -- Methodist Le Bonheur Healthcare recently launched Welcome Bluff City Baby, a pilot program designed to encourage reading and literacy interaction from birth.

SILVER SPRING, Md., Feb. 21, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today authorized marketing of the first test to detect a genetic condition known as Fragile X Syndrome (FXS), the most common known cause of inherited developmental delay and intellectual disability. The test is intended as an aid in diagnosing FXS and is to be used along with th

NEW YORK, Feb. 21, 2020 /PRNewswire/ -- Synapse Medical Communications (Synapse), a leader in analytics-driven commercialization solutions, announced that its "AZOncologyID" website has been named the Gold winner of the 2019 PM360 Pharma Choice Awards, in the Professional Website category, and its "BiomARker Experience Augmente